Zephyr™ Performance Systems, now a part of Medtronic, is a global leader in real-time physiological and biomechanical monitoring solutions for the Defense, First Responder, and Pro and Collegiate sports markets.
Medtronic is working with new partners, in new ways to improve global healthcare. With the integration of Covidien as our Minimally Invasive Therapies Group, we can address the healthcare needs of more people around the world than ever.
We are committed to improving lives through our medical technologies and solutions. By joining together with Covidien, we can accelerate and advance our ability to create meaningful innovations for hospitals, health systems and healthcare providers so they can deliver the best care possible to patients and their families around the world.
We recognize that innovation is only meaningful if it is safe, effective and usable. That’s why we are partnering with health systems and providers to combine our capabilities with their expertise to change the way we work together to achieve the best outcomes.
With changing healthcare demands, companies that deliver health products and services must be willing to do things differently. The union of Medtronic and Covidien demonstrates that we are committed to thinking differently in solving problems to deliver better health. As we go forward, we will keep you updated about how this approach is succeeding in ensuring better health for more people.